Compare Cassava Sciences Inc (FLNA) vs Sunrun Inc (RUN) Price & Performance

FLNA is trading at $0.9401, down 5.74% on the day, with a bearish technical signal from moving averages. The company shows consistent quarterly earnings beats but remains unprofitable with negative ROE of -55.79% and negative cash flow. Analyst sentiment is positive with 67% buy ratings, though the stock faces fundamental challenges with ongoing operational losses.

The outlook remains challenged by persistent losses and negative cash flow, though recent earnings beats and strong analyst support provide potential upside. Key risks include the company's ability to achieve profitability and sustain operations given current burn rate. The biotechnology focus on TSC-related epilepsy represents both opportunity and execution risk.

Sunrun (RUN) trades at $9.84, down 0.3% on the day, with bearish technical signals and mixed fundamentals. The stock shows attractive valuation metrics with P/E of 6.82 and P/B of 0.69, but faces operational challenges with negative operating cash flow. Recent Q2 2026 earnings beat expectations with $0.42 EPS versus $0.23 estimate, though guidance cuts and a Goldman Sachs price target reduction to $15 weighed on sentiment.

The outlook remains cautious despite strong analyst consensus (62% buy ratings) and $14.38 price target. Key opportunities include record storage attachment rates and securitization success, while risks involve negative cash flow trends, high debt levels (70.76% debt-to-asset ratio), and solar industry volatility. The stock trades 31.6% below analyst consensus target, offering potential upside if execution improves.